Table 3:
Predictors of steatosis (CAP ≥245 dB/m) by multivariate logistic regression analysis
| Variable | Odds ratio (95% CI) | p-value |
|---|---|---|
| Moderate alcohol use | 1.36 (0.65–2.89) | >0.05 |
| Past HBV/HCV† | 0.78 (0.58–1.29) | >0.05 |
| Dyslipidemia | 2.25 (0.70–6.65) | >0.05 |
| Diabetes mellitus | 10.47 (1.42–75.35) | <0.05* |
| Hypertension | 5.15 (1.75–15.38) | <0.05* |
| BMI ≥30, kg/m2 | 16.47 (5.56–45.56) | <0.05* |
| BMI ≥25, kg/m2 | 10.1 (1.88–37.14) | <0.05* |
| Male | 0.69 (0.39–1.87) | >0.05 |
| APRI ≥0.7 | 1.07 (0.26–4.27) | >0.05 |
| FIB-4 ≥1.45 | 1.80 (0.79–4.10) | >0.05 |
* Statistically significant
† Hepatitis C post sustained virologic response or past hepatitis B infection (surface antigen negative and core antibody positive) CAP = Computed attenuation parameter;
HBV = Hepatitis B virus; HCV = Hepatitis C virus; APRI = Aspartate aminotransferase to platelet ratio index; FIB-4 = Fibrosis-4 index